Actual Medicinal Product (AMP) -
Bydureon BCise 2mg/0.85ml prolonged-release suspension for injection pre-filled pens (AstraZeneca UK Ltd)
Name Details
|
Current Name
Bydureon BCise 2mg/0.85ml prolonged-release suspension for injection pre-filled pens
|
Start Date
26-02-2020
|
End Date
|
|
Previous Name
Bydureon 2mg/0.85ml prolonged-release suspension for injection pre-filled pens
|
Start Date
03-02-2020
|
End Date
25-02-2020
|
|
|
Abbreviated Name
Bydureon BCise 2mg/0.85ml prolonged-release inj pf pens
|
Start Date
26-02-2020
|
|
| Bydureon 2mg/0.85ml prolonged-release inj pre-filled pens |
Previous Start Date
03-02-2020
|
Previous End Date
25-02-2020
|
Summary
- Licensed Route
- Subcutaneous
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
Codes
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 38060511000001101 |
03-02-2020 |
|
Actual Medicinal Product Pack (AMPP) Information